Admiral Acquisition Limited Suspension of Securities

RNS Number : 2465Y

Admiral Acquisition Limited

30 July 2024

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

For immediate release

Acuren Corporation (formerly known as Admiral Acquisition Limited)

SUSPENSION OF SECURITIES

30 July 2024 - Acuren Corporation (formerly known as Admiral Acquisition Limited (LSE: ADMR / ADMW) (the "Company") announces that further to its announcement of 19 July 2024 and in anticipation of the expected closing of the Company's acquisition of ASP Acuren Holdings, Inc., from funds advised by American Securities LLC, (the "Transaction"), the listing of the Company's ordinary shares (ISIN: VGG0093S1092) (the "Shares") and warrants (ISIN: VGG0093S1175) (the "Warrants") on the Official List of the Financial Conduct Authority (the "FCA") and the trading of the Shares and the Warrants on the main market for listed securities on the London Stock Exchange were suspended at the Company's request, with effect from the start of trading today, Tuesday, 30 July 2024.

The Company expects the Transaction to close during US business hours today, 30 July 2024. Further announcements will be made in due course.

Enquiries:

Ed Hammond

[e-mail]

[phone]

 

Dan Moore

[e-mail]

[phone]

IMPORTANT NOTICES

Neither the content of the Company's website, nor any website accessible by hyperlinks on either of those websites is incorporated in, or forms part of, this announcement. 

FORWARD LOOKING STATEMENTS AND DISCLAIMERS

This announcement does not constitute or form part of any offer or invitation to purchase, otherwise acquire, issue, subscribe for, sell or otherwise dispose of any securities, nor any solicitation of any offer to purchase, otherwise acquire, issue, subscribe for, sell, or otherwise dispose of any securities in the United States or in any other jurisdiction. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the issuer and will contain detailed information about the company and management, as well as financial statements.

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

Certain statements in this announcement are forward-looking statements which are based on the Company's expectations, intentions and projections regarding the Company's future performance, anticipated events or trends and other matters that are not historical facts. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements may, and often do, differ materially from actual results. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law or regulation, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Nothing in this announcement constitutes or should be construed as constituting a profit forecast.

Legal Entity Identifier (LEI): 213800ZDFRNC8QXEZ481

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

SRSSEWFEUELSEDW